Merit Medical Systems Gestione
Gestione criteri di controllo 3/4
Merit Medical Systems Il CEO è Fred Lampropoulos, nominato in Jul1987, e ha un mandato di 37.33 anni. la retribuzione annua totale è $ 10.05M, composta da 18.8% di stipendio e 81.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.97% delle azioni della società, per un valore di $ 113.62M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.2 anni e 4.8 anni.
Informazioni chiave
Fred Lampropoulos
Amministratore delegato
US$10.1m
Compenso totale
| Percentuale dello stipendio del CEO | 18.8% |
| Mandato del CEO | 37.3yrs |
| Proprietà del CEO | 2.0% |
| Durata media del management | 5.2yrs |
| Durata media del Consiglio di amministrazione | 4.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Merit Medical Systems, Inc. (NASDAQ:MMSI) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02
Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Nov 01Merit Medical Systems - Impressive Momentum
Sep 17The Price Is Right For Merit Medical Systems, Inc. (NASDAQ:MMSI)
Sep 17Why Merit Medical Systems, Inc. (NASDAQ:MMSI) Could Be Worth Watching
Sep 04Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
Aug 22These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Jul 31Merit Medical Systems: Steady Wins The Day
Jul 05Merit Medical Systems (NASDAQ:MMSI) Ticks All The Boxes When It Comes To Earnings Growth
Jun 19Merit Medical: Undervalued With Multiple Growth Drivers In Play
Jun 15Merit Medical Systems (NASDAQ:MMSI) Is Doing The Right Things To Multiply Its Share Price
May 23It Looks Like Shareholders Would Probably Approve Merit Medical Systems, Inc.'s (NASDAQ:MMSI) CEO Compensation Package
May 09Results: Merit Medical Systems, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 03Is Merit Medical Systems (NASDAQ:MMSI) Using Too Much Debt?
Apr 30Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Apr 16When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Apr 02Merit Medical Systems: Solid Performer, Fully Valued
Mar 03Analyst Estimates: Here's What Brokers Think Of Merit Medical Systems, Inc. (NASDAQ:MMSI) After Its Full-Year Report
Mar 02We Ran A Stock Scan For Earnings Growth And Merit Medical Systems (NASDAQ:MMSI) Passed With Ease
Feb 05The Returns At Merit Medical Systems (NASDAQ:MMSI) Aren't Growing
Jan 23What You Can Learn From Merit Medical Systems, Inc.'s (NASDAQ:MMSI) P/E
Dec 18These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
Nov 21What Is Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Share Price Doing?
Nov 06Estimating The Fair Value Of Merit Medical Systems, Inc. (NASDAQ:MMSI)
Oct 23Does Merit Medical Systems (NASDAQ:MMSI) Deserve A Spot On Your Watchlist?
Sep 11Return Trends At Merit Medical Systems (NASDAQ:MMSI) Aren't Appealing
Aug 13Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jul 31Is Merit Medical Systems (NASDAQ:MMSI) A Risky Investment?
Jul 17Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Jun 07Is It Time To Consider Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
May 01We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Apr 16Returns On Capital At Merit Medical Systems (NASDAQ:MMSI) Have Hit The Brakes
Apr 02Is Now The Time To Put Merit Medical Systems (NASDAQ:MMSI) On Your Watchlist?
Mar 01Merit Medical Systems, Inc.'s (NASDAQ:MMSI) Intrinsic Value Is Potentially 24% Below Its Share Price
Feb 01Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Jan 12Merit Medical Systems (NASDAQ:MMSI) Seems To Use Debt Rather Sparingly
Dec 29Here's Why We Think Merit Medical Systems (NASDAQ:MMSI) Is Well Worth Watching
Nov 23Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$120m |
| Jun 30 2024 | n/a | n/a | US$117m |
| Mar 31 2024 | n/a | n/a | US$102m |
| Dec 31 2023 | US$10m | US$2m | US$94m |
| Sep 30 2023 | n/a | n/a | US$100m |
| Jun 30 2023 | n/a | n/a | US$90m |
| Mar 31 2023 | n/a | n/a | US$85m |
| Dec 31 2022 | US$8m | US$2m | US$75m |
| Sep 30 2022 | n/a | n/a | US$62m |
| Jun 30 2022 | n/a | n/a | US$58m |
| Mar 31 2022 | n/a | n/a | US$48m |
| Dec 31 2021 | US$8m | US$2m | US$48m |
| Sep 30 2021 | n/a | n/a | US$43m |
| Jun 30 2021 | n/a | n/a | US$28m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$8m | US$2m | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$29m |
| Jun 30 2020 | n/a | n/a | -US$30m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | US$5m | US$2m | US$5m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$39m |
| Mar 31 2019 | n/a | n/a | US$43m |
| Dec 31 2018 | US$4m | US$2m | US$42m |
| Sep 30 2018 | n/a | n/a | US$40m |
| Jun 30 2018 | n/a | n/a | US$19m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$4m | US$1m | US$28m |
Compensazione vs Mercato: La retribuzione totale di Fred ($USD 10.05M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 8.06M ).
Compensazione vs guadagni: La retribuzione di Fred è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Fred Lampropoulos (74 yo)
37.3yrs
Mandato
US$10,052,664
Compensazione
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman and Chief Executive Officer since Jul...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 113.6m | |
| President | less than a year | US$2.81m | 0.060% $ 3.4m | |
| CFO & Treasurer | 6.5yrs | US$2.77m | 0.013% $ 737.0k | |
| Chief Operating Officer | 2.6yrs | US$2.71m | 0.025% $ 1.5m | |
| Chief Legal Officer & Corporate Secretary | 8.6yrs | US$2.66m | 0.030% $ 1.7m | |
| Chief Information Officer | 1.8yrs | Nessun dato | Nessun dato | |
| Vice President of Global Communications | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Global Marketing & Strategy | no data | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 3.9yrs | Nessun dato | Nessun dato | |
| Chief Regulatory Affairs Officer | 11.8yrs | Nessun dato | Nessun dato | |
| Managing Director of Operation Merit Medical Tijuana | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Merit Medical EMEA | no data | Nessun dato | Nessun dato |
5.2yrs
Durata media
55.5yo
Età media
Gestione esperta: Il team dirigenziale di MMSI è esperto e expertise (durata media dell'incarico 5.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 37.3yrs | US$10.05m | 1.97% $ 113.6m | |
| Independent Director | 2.5yrs | US$275.99k | 0.0052% $ 301.1k | |
| Lead Independent Director | 9.3yrs | US$320.99k | 0.051% $ 3.0m | |
| Independent Director | 7.5yrs | US$290.99k | 0.029% $ 1.7m | |
| Independent Director | 4.4yrs | US$290.99k | 0.018% $ 1.0m | |
| Independent Director | 5.3yrs | US$295.99k | 0.010% $ 589.0k | |
| Independent Director | 3.4yrs | US$275.99k | 0.0080% $ 463.5k | |
| Independent Director | less than a year | Nessun dato | Nessun dato |
4.8yrs
Durata media
63.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MMSI sono considerati esperti (durata media dell'incarico 4.8 anni).